Rare diseases
Investigational molecules
Locations
Michalakopoulou 88, 115 28 Athens, Greece
The sponsor’s research activity is centered on sepsis, with attention to infection-driven inflammatory states, immune endotypes, and outcomes linked to organ dysfunction and mortality. Its trials include biomarker-informed approaches and targeted immunomodulation in patients with high-risk infection profiles.
Research in this area also addresses early recognition of deterioration in emergency and acute care settings, with a focus on identifying patients most likely to benefit from tailored intervention.
Hellenic Institute For The Study Of Sepsis runs clinical trials in conditions such as Sepsis, Post-acute COVID-19 syndrome, Bacterial infection, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on Early Clarithromycin Treatment to Prevent Sepsis in Patients with Community-Acquired Pneumonia
GreeceStudy on Anakinra for Patients with Long COVID and Ongoing Respiratory Symptoms
GermanyClarithromycin to prevent secondary infections in adult patients with community-acquired pneumonia-related sepsis
GreeceA study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department
GreeceStudy on Avibactam and Drug Combination for Treating Severe Infections in Patients
GreeceStudy on Emapalumab for Patients with Sepsis Linked to Interferon-Gamma
GreeceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
